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32 INTRODUCTION
33 Accurate measurements of hip outcomes and function are vital in the study of hip pathology. 
34 Additionally, outcome measures can also be used in the clinical realm to track progress of treatment. 
35 Several outcome measures have been developed in an effort to accurately assess hip symptoms and 
36 function. A 2011 review of the most commonly used hip outcome scores was previously published in this 
37 journal (1). Since then, a number of additional studies focusing on these outcomes scores have been 
38 published to further refine our knowledge and potential utility of hip outcome scores. The purpose of 
39 review is to provide updated information with regards to the most commonly used hip outcome scores 
40 which include the Harris Hip Score (HHS), the Hip Disability and Osteoarthritis Outcome Score (HOOS), 
41 Patient-Reported Outcomes Measurement Information System (PROMIS), the Oxford Hip Score (OHS), 
42 the Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), the American Academy of 
43 Orthopedic Surgeons (AAOS) Hip and Knee questionnaire, and the Western Ontario and McMaster 
44 Universities Osteoarthritis Index (WOMAC).
45
46 HARRIS HIP SCORE (HHS)
47 Description
48 Purpose. The HHS was initially developed for the assessment of the results of hip surgery, specifically 
49 mold arthroplasties for post-traumatic osteoarthritis of the hip, in 1969 (2). It is now intended to 
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51 Content. The original HHS covers pain, function, absence of deformity, and range of motion. The pain 
52 domain measures pain severity and its effect on activities and need for pain medication. The function 
53 domain assesses daily activities (stair use, using public transportation, sitting, and managing shoes and 
54 socks) and gait. Deformity evaluates hip flexion, adduction, internal rotation, and extremity length 
55 discrepancy. Range of motion measures hip flexion, abduction, external and internal rotation, and 
56 adduction.
57 A modified version is also now available (HHS-modified) which only assess the pain and function 
58 components of the HHS. (3,4)
59 Number of items. In the original HHS, there are 10 items. In the HHS-modified, there are 8 items.
60 Response options/scale. The original HHS has a maximum of 100 points (best possible outcome) 
61 covering pain (1 item, 0-44 points), function (7 items, 0-47 points), absence of deformity (1 item, 4 
62 points), and range of motion (2 items, 5 points). The only includes pain and function, so has a maximum 
63 of 91 points, however, the score is multiplied by 1.1 to get a maximum of 100.
64 Recall period for items. Not described
65 Cost to use. Free
66 How to obtain. Available in original article (2). URL: http://www.orthopaedicscore.com/ , 
67 http://www.ncbi.nlm.nih.gov/pubmed/5783851. Modified HHS can be obtained by only completing the 
68 pain and function components, then multiplying the score by 1.1.
69
70 Practical application
71 Method of administration. The HHS is a clinician-based outcome measure administered by a qualified 
72 health care professional such as a physician or a physical therapist. The modified HHS is a self-
73 administered instrument.
74 Scoring. Each item has a unique numerical scale, which corresponds to descriptive response options. 
75 The number of response options as well as the number of points assigned varies by each item. In the 
76 original HHS, the range of motion item consists of six motions graded. Each range of motion factor is 
77 assigned an index factor and a maximum possible value. These points are added and multiplied by 0.05 
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79 the 4 domains. The modified HHS is calculated by summing the pain and function components of the 
80 scale and multiplying by 1.1.
81 Score interpretation. Both the HHS and modified HHS have a maximum of 100 points. The higher the 
82 HHS, the less dysfunction. Scores below 70 are typically considered a poor result. 70-80 is considered 
83 fair, 80-90 is good, and 90-100 is considered excellent (2). Pain and function are the major score 
84 contributors with 44 points possible for pain and 47 possible for function (14 for activities of daily living 
85 and 33 for gait). Range of motion has a maximum of 5 points and deformity has a maximum of 4 points.
86 Respondent time to complete. Takes approximately 5 minutes to complete.
87 Administrative burden. No formal training is necessary to administer.
88 Translations/adaptations. The HHS has been used internationally (USA, Canada, Sweden, Europe, etc.), 
89 but there are no validated versions in other languages.
90
91 Psychometric information
92 Floor and ceiling effects. Unacceptable ceiling effects for the HHS were reported in 31 of 59 studies (5). 
93 Pooled data across studies (n of 6,667 patients) suggested ceiling effects of 20% (95% CI 18-22). The 
94 modified HHS had reported ceiling effects of 27.5% (6). In a population of 294 patients who underwent 
95 periacetabular osteotomy, the modified HHS had reported ceiling effects of 1% (7). 
96 Reliability. For the original HHS, the test-retest reliability for total score was excellent for physicians (r = 
97 0.94) and physiotherapists (r = 0.95). Both physicians and physiotherapists had excellent test-retest 
98 reliability for pain and function (r = 0.93-0.98)  (8). The interrator correlations were good to excellent in 
99 two previous studies (0.74 – 1.0)  (8,9). 
100 The modified HHS was shown to have excellent reliability with a Cronbach’s alpha score of 0.95 
101 and high intraclass correlation (0.91 – 0.95)  (10).
102 Validity. The content validity of the HHS has been tested by comparisons to the Western Ontario and 
103 McMaster Universities Osteoarthritis Index (WOMAC) and the Short Form 36 (SF-36). The HHS has 
104 demonstrated no major differences when compared to these scores (8). In assessment of construct 
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106 WOMAC, the Nottingham Health Profile, and the SF-36  (8,11). The correlation between the HHS and SF-
107 36 is notably strong in the physical domains, and weak in the mental domains.
108 The modified HHS has been compared to the SF-12 physical and mental subscale for validity and 
109 was shown to have poor correlation with the mental subscale, but strong correlation with the physical 
110 subscale (7).
111 Responsiveness. In a study of 335 total hip arthriplasties (THA), the HHS was found to be responsive to 
112 pain and function at six-month post-operative follow-up, but weak at two-year follow-up (12). In a study 
113 of 293 periacetabular osteotomies, the modified HHS was found to be adequately responsive (7). 
114 Minimally important differences. In a study assessing the HHS in femoral neck fractures at four and 12 
115 months post-operatively, the standardized response mean was 0.75 which was the best in ability to 
116 detect change when compared to the Barthel Index and the EuroQol 5-domain (EQ-5D) (13). The 
117 modified HHS was shown to have the lowest minimal clinically important difference when compared to 
118 the WOMAC and HOOS (7). 
119 Generalizability. Both the HHS and the modified HHS are generalizable to adult patients with hip 
120 disabilities or undergoing hip surgeries.
121 Use in clinical trials. Both the HHS and the modified HHS have been used extensively in clinical trials 
122 involving hip pathology and treatment of different hip conditions. The HHS has been used in trials that 
123 range from assessment of treatment choice for femoral neck and intertrochanteric femur fractures 
124 fractures to assessment of effectiveness of different injections for osteoarthritis of the hip (14–17). The 
125 HHS is also a popular tool in studies relating to THAs given the focus of the measure on pain and 
126 impaired physical function, which are the main indications for a THA (18–20). Similarly, the modified 
127 HHS is widely used in clinical trials relating to hip pathology including injections, management of hip 
128 fractures, hip arthroscopy, and THAs (21–25). The modified HHS has the benefit in clinical trials over HHS 
129 of being self-administered and not requiring a clinician for assessment.
130
131 Critical appraisal of overall value to the rheumatology community
132 Strengths. As discussed above, the HHS and modified HHS are both widely used in evaluating outcomes 
133 of THA given the focus on evaluation of pain and physical function (26). Additionally, the HHS and 
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135 for treatment of femoral neck fractures, hip arthroscopy, and conservative management of hip 
136 osteoarthritis (7,13,27).
137 Caveats and cautions. The main criticism of the HHS are the ceiling effects which limit its validity (5).
138 Clinical usability. The psychometric evaluation does not support interpretation of scores to make 
139 decisions for individuals. 
140 Research usability. As long as the researcher is aware of the ceiling effects, both the HHS and modified 
141 HHS can be used for clinical outcome studies for a variety of hip pathologies.
142
143 HIP DISABILITY AND OSTEOARTHRITIS OUTCOME SCORE (HOOS)
144 Description
145 Purpose. The HOOS was developed as an adaptation of the Knee injury and Osteoarthritis Outcome 
146 Score (KOOS), which itself is an adaptation of the WOMAC. It was created as an instrument of 
147 assessment of an adult patients’ opinion about their hip and hip disability. The HOOS was originally 
148 developed in 2003 and has been validated in two different versions (28).
149 Several variations of the HOOS have also been developed, the HOOS – Joint Replacement 
150 (HOOS-JR) short form and the HOOS – Physical Function (HOOS-PS) short form (29,30) and the HOOS-12. 
151 The HOOS-JR is a six-item instrument developed specifically for patients undergoing THA measuring the 
152 domains of pain and activities of daily living (ADLs). The HOOS-PS is a five-item measure of physical 
153 function designed to elicit patients’ opinions about difficulties experienced due to their hip problems. 
154 The HOOS-12 is a 12-item HOOS retains the 3 subscores (pain, function/ADL, and quality of life).
155 Content. HOOS consists of five subscales: pain, other symptoms, function in ADLs, function in sport and 
156 recreation, and hip related quality of life (QOL). The HOOS-JR measures only the domains of pain and 
157 ADLs. The HOOS-PS measures physical function.
158 Number of items. The original HOOS contains 40 items total: 10 for pain, 5 for other symptoms, 17 for 
159 function in ADLs, 4 for function in sports and recreation, and 4 for hip-related QOL. The HOOS-JR 
160 contains 6 items total: 2 for pain and 4 for function. The HOOS-PS contains 5 items total all relating to 
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162 Response options/scale. In the HOOS, HOOS-JR, and HOOS-PS, standardized answer options are given in 
163 5 Likert boxes. Each question is scored 0-4. Scores are summarized and transformed into a 0-100 scale. A 
164 score of 0 indicates extreme problems and 100 indicating no problems.
165 Recall period for items. The last week is taken into consideration for the questions.
166 Cost to use. Free
167 How to obtain. The HOOS, HOOS-PS, and HOOS-12  can be obtained at www.koos.nu. The HOOS-JR can 
168 be obtained from www.aaos.org/uploadedFiles/HOOS-JR-2016.pdf. 
169
170 Practical application
171 Method of administration. The questionnaire for all forms of HOOS is patient reported.
172 Scoring. The manual scoring sheet is available from the above websites. Included are instructions for 
173 handling missing values. Computer scoring can increase clinical usefulness.
174 Score interpretation. Scores can range from 0-100 and each subscale can have scores from 0-100 where 
175 0 indicates extreme problems and 100 indicates no problems. The HOOS scores within each subscale 
176 (pain, symptoms, ADLs, sports/rec, QOL) can be plotted for comparison of pre-intervention and post-
177 intervention comparison visualization.
178 Respondent time to complete. The original HOOS takes 10-15 minutes for a subject to complete. The 
179 HOOS-JR, HOOS-PS, and HOOS-12 all take under 5 minutes to complete.
180 Administrative burden. Minimal administrative burden. Hand scoring of the HOOS can take 10-15 
181 minutes without additional training. Computerized scoring can automate this process for instantaneous 
182 results without further administrative need.
183 Translations/adaptations. The HOOS is available in 25 total languages including English, French, 
184 German, Dutch, Italian, and Spanish among others (available on www.koos.nu). A number of 
185 adaptations of the HOOS exist including the knee injury and osteoarthritis outcome score (KOOS), knee 
186 injury and osteoarthritis score for children (KOOS-Child), foot and ankle outcome score (FAOS), 
187 rheumatoid and arthritis outcome score (RAOS), hip and groin outcome score (HAGOS), and neck 
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189
190 Psychometric information
191 Floor and ceiling effects. Floor and ceiling effects have been reported in different subscales within the 
192 HOOS. Floor effects have been reported to range 4.1-17.8% in the sport/rec subscale in subjects eligible 
193 for THA and patients with hip osteoarthritis (31–33). Ceiling effects have been reported in THA in all 
194 subscales of the HOOS (31). No floor effects have been reported in the hip arthroscopy population, 
195 however, ceiling effects were reported 12 and 24 months post-operatively in the ADL and sport/rec 
196 subscales (34).
197 The HOOS-JR has been shown to have low floor effects (0.6-1.9%), but ceiling effects up to 37-
198 46% after THA (29). Floor and ceiling effects of the HOOS-PS have only been studied in the French 
199 translation of the HOOS-PS, but no floor or ceiling effects were observed (33).
200 Reliability. The reliability of the HOOS has been examined in patients treated conservatively for hip 
201 osteoarthritis, patients treated with THA, and for patient undergoing hip arthroscopy (28,31–34). In THA 
202 patients, the internal consistency ranged from 0.82-0.98 (Cronbach’s alpha coefficient) with the ADL 
203 subscale having the highest consistency of 0.94-0.98 (28,32,33). The test-retest reproducibility has been 
204 shown to be high in the THA population with an intraclass correlation coefficient of 0.75-0.97 (28,32,33). 
205 In the hip arthroscopy population, the test-retest reliability was excellent with intraclass correlation 
206 coefficients ranging from 0.91-0.97 (34).
207 The HOOS-JR was shown to have acceptable internal consistency as measured by Person 
208 Separation Index (PSI) of 0.86 (29). Test-retest reliability was not reassessed in the HOOS-JR. The HOOS-
209 PS was shown to have an intraclass correlation coefficient of 0.86 (33).
210 Validity. The HOOS content validity was performed by asking patients to rate item importance (28,31). 
211 Construct validity has been confirmed in hip osteoarthritis, THA, and hip arthroscopy studies by 
212 comparison to the SF-36, Oxford Hip Score (OHS), and Lequesne Index, and visual analog scale for pain 
213 (31–34). The HOOS-JR and HOOS-12 construct validity was confirmed with high correlations with the 
214 pain and ADL domains of HOOS and the pain and function domains of the WOMAC with moderate 
215 correlations with the other domains of the HOOS and WOMAC scores (29). 
216 Responsiveness. All domains of the HOOS were found to be responsive in hip arthroscopy at 9 and 12-
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218 the HOOS was found to be responsive at 12-month follow-up (7). The HOOS-JR and HOOS-12 were 
219 found to have very high responsiveness up to 2-years post-operatively (29). The HOOS-PS was also 
220 found to have good responsiveness, but was only assessed 1-month post-operatively (33).
221 Minimally important differences. The smallest detectable difference of the HOOS ranged from 9.6 for 
222 the ADL domain to 16.2 in the QOL domain (33). In hip arthroscopy, the minimal detectable change 
223 ranged from 9 for ADL to 19 in the QOL domain (34). 
224 Generalizability. The HOOS is generalizable to adult populations with hip ailments or undergoing hip 
225 procedures. The HOOS-JR was developed for patients undergoing THA.
226 Use in clinical trials. The HOOS has been used extensively in clinical trials relating to hip osteoarthritis 
227 and hip pathology. The HOOS is one of the more common patient reported measures of hip function and 
228 post-operative outcomes. It has been used extensively in THA clinical studies  (35–37), hip dysplasia 
229 surgery (38,39), hip arthroscopy (40), and even in development of pain management protocols after hip 
230 surgery (41). The HOOS-JR has only existed since 2016 and is intended mainly for THA, but it has been 
231 used in recent trials related to THA outcomes (42,43). The HOOS-PS has also been used in clinical trials 
232 relating to hip surgery, but is used far less frequently than the original HOOS (18,44,45).
233
234 Critical appraisal of overall value to the rheumatology community
235 Strengths. The HOOS can be used for younger and more active patients given the subscales and 
236 individual domains. The HOOS has shown favorable qualities in reviews of psychometric properties in 
237 assessment of patients after THA, hip arthroscopy, periacetabular osteotomy, and patients with hip 
238 osteoarthritis not undergoing surgery (7,34,46,47).
239 Caveats and cautions. The HOOS is overall well received, however, it does have ceiling effects in all 
240 domains which are also present in the HOOS-JR (29,34).
241 Clinical usability. The HOOS can be used to follow patients with hip conditions over time in clinic. The 
242 HOOS-JR can be used in clinics which perform THA for monitoring patients.
243 Research usability. The HOOS, HOOS-JR, HOOS-12, and HOOS-PS are all usable in the research setting 
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246 PATIENT-REPORTED OUTCOMES MEASUREMENT INFORMATION SYSTEM (PROMIS)
247 Description
248 Purpose. PROMIS was developed in 2004 by the National Institutes of Health (NIH) for use in clinical 
249 care and medical research (48). This system was intended to be used across multiple specialties, be 
250 publically available, precise, and flexible.
251 Content. The PROMIS adult profile covers three domains: physical health, mental health, and social 
252 health. Within each of these domains are more specific profile domains. Profile domains under physical 
253 health include fatigue, pain intensity, pain interference, physical function, and sleep disturbance. Profile 
254 domains under mental health include anxiety and depression. Within orthopaedics, the PROMIS physical 
255 function, pain interference, and depression domains have been most commonly used (49–53).  
256 Number of items. There are multiple options of measures within PROMIS which can vary in the number 
257 of items. The short forms (SFs) are a fixed set of 4-10 items for one individual domain. Computer 
258 adaptive tests (CATs) provide items selected dynamically from an item bank based upon the subject’s 
259 previous answers. The CATs are usually 4-12 items in length. Profiles are fixed collections of SFs from 7 
260 different domains. Several versions of PROMIS Profiles exist ranging from 4-8 questions per domain.
261 Response options/scale. PROMIS uses a T-score metric. 50 is designed to be the mean of the population 
262 and 10 is one standard deviation (SD) of the population. Therefore, a score of 60 would indicate that 
263 subject is one SD above the mean for the population within the measured domain. Response options of 
264 the questions depend on the category of question. Pain is typically measured on a 0-10 point scale. 
265 Frequency, duration, intensity, and capability related questions typically have a scale of five variable 
266 options. 
267 Recall period for items. Most PROMIS items use a 7-day recall period. However, typically within the 
268 physical function domain, the question is assessed in the present tense.
269 Cost to use. Free
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274 Method of administration. PROMIS scales are administered via paper or computer-based forms.
275 Scoring. Scoring manuals are available on the HealthMeasures website to allow conversion of the score 
276 to a T-score. PROMIS measures are scored on a T-score metric. 50 is designed to be the mean of the 
277 population and 10 is one SD of the population. Therefore, a score of 60 would indicate that subject is 
278 one SD above the mean for the population within the measured domain.
279 Score interpretation. A score of 50 indicates the subject measures at the mean of the population in that 
280 particular metric. One SD is 10 points. Therefore, a score of 60 would indicate that subject is one SD 
281 above the mean for the population within the measured domain.
282 Respondent time to complete. PROMIS domains relating to hip pathology typically take less than 5-10 
283 minutes for the subject to complete.
284 Administrative burden. Minimal overall administrative burden. However, the distributor must have 
285 access to the scoring manuals for interpretation of the subjects’ responses.
286 Translations/adaptations. The PROMIS adult domains are available in over 45 different languages 
287 including English, Spanish, French, German, Dutch, and Italian. 
288
289 Psychometric information
290 Floor and ceiling effects. There has been little overall study on psychometric properties of the PROMIS 
291 score in relation to hip pathology. In a study of patients who underwent periacetabular osteotomy for 
292 symptomatic hip dysplasia, PROMIS showed no floor or ceiling effects both pre and post-operatively 
293 (39). When studied in patients who underwent THA for symptomatic hip osteoarthritis, the PROMIS 
294 depression domain showed floor effects up to 20% pre-operatively and 30-45% post-operatively (54). In 
295 the same study, the PROMIS pain interference domain showed no floor effects pre-operatively, but floor 
296 effects of 21-26% at 1 year post-operatively. No ceiling effects were observed in the depression, pain 
297 interference or physical function scores pre or post-operatively.
298 Reliability. Few studies have assessed the reliability of PROMIS instruments related to treatment of hip 
299 pathology. One study examining the psychometric properties of one CAT of the PROMIS (the lower 
300 extremity CAT) compared to the modified HHS and the Hip Outcome Score showed excellent reliability 
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302 Validity. To our knowledge, content validity of PROMIS instruments have not been evaluated specifically 
303 for hip pathology. Group validity has been assessed previously in patients with a general diagnosis of 
304 “osteoarthritis”, but not specifically for hip osteoarthritis (55).
305 Responsiveness. Responsiveness of PROMIS instruments for hip pathology has been evaluated in study 
306 of patients who underwent THA. The pain interference and physical function domains were found to 
307 have high responsiveness post-operatively in patients with hip osteoarthritis after THA (54).
308 Minimally important differences. Minimally clinically important difference (MCID) has typically been 
309 defined as 5, half of the normalized SD of reported PROMIS scores (SD=10). In a study of patients who 
310 underwent THA, 66-78% of patients had a MCID post-operatively in the pain interference domain, 61-
311 75% of patients had a MCID in the physical function domain, and 44-46% of patients had MCID in the 
312 depression domain (54).
313 Generalizability. PROMIS scores are generalizable to adult populations with hip ailments or undergoing 
314 hip procedures. There are separate PROMIS instruments for pediatric patients.
315 Use in clinical trials. Compared to other measures of hip function and symptoms, PROMIS instruments 
316 have been used relatively less frequently in clinical trials. However, more recent studies have begun to 
317 use PROMIS instruments in assessment of outcomes related to surgical intervention for different hip 
318 pathologies. Clinical studies on outcomes after THA have used PROMIS scores for assessment of both 
319 functional outcomes and pain improvement post-operatively (56,57). PROMIS instruments have been 
320 used in clinical trials assessing baseline disability and functional performance in patients with 
321 femoracetabular impingement (FAI) (58,59). Lastly, PROMIS scores were used in one clinical trial 
322 studying post-operative outcomes of correction of mildly dysplastic hips with periacetabular ostoetomy 
323 (60).
324
325 Critical appraisal of overall value to the rheumatology community
326 Strengths. PROMIS instruments have the benefit of adaptability to patient responses to enable the 
327 questionnaire be adaptable to individual patients. Additionally, PROMIS instruments are becoming more 
328 widely used in all fields of healthcare. Therefore, if used in hip pathology, it has the potential added 
329 benefit of easier interpretation by healthcare practitioners or researchers who may not be as familiar 
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331 Caveats and cautions. There is a relative paucity of literature involving psychometric properties of 
332 PROMIS instruments in patients with hip pathology. Further investigation should be performed in this 
333 area. Additionally, high floor effects have been reported in a previous THA study as mentioned 
334 previously (54).
335 Clinical usability. Although PROMIS instruments have not been extensively used in assessment of 
336 outcomes in patients with hip pathology, it can be used to follow patients both pre and post-operatively.
337 Research usability. Further evaluation of the psychometric properties of PROMIS instruments 
338 specifically for hip pathology would be beneficial, however, PROMIS instruments have been used in 
339 several clinical trials involving THA, FAI, and hip dysplasia (56–60). Investigators should take note of the 
340 previously reported high floor effects in THA populations (54).
341
342 OXFORD HIP SCORE (OHS)
343 Description
344 Purpose. To assess outcome after total hip arthroplasty (THA) by measuring a patient’s perceptions after 
345 surgery. Originally described in 1996 and was updated in 2007 (61,62).
346 Content. OHS assess his pain (6 items) and function (6 items) of the hip in relation to daily activities such 
347 as walking, dressing, slipping, etc.
348 Number of Items. 12 items with 5 categories of response; no subscale’s.
349 Response options/scale. The original scoring system as described by Dawson et al in 1996 ranged from 
350 1-5 (best to worst) with a total score of 12-60 (least difficulties to most difficulties). This scoring system 
351 was modified in 2007 by Murray et al to new item ranges of 0-4 (worse to best) with total scores ranging 
352 from 0-48 (most difficulties to least difficulties) (62,63).
353 Recall period for Items. During the past 4 weeks.
354 Examples of Use. This patient reported outcome measure has been used and several countries in both 
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358 How to obtain. The Oxford Hip Score questionnaire is free to use and is available online at 
359 http://www.orthopaedicscore.com/scorepages/oxford_hip_score.html. Further information the Oxford 
360 Hip Score and all the other Oxford Orthopaedic Scores can be found at 
361 https://phi.uhce.ox.ac.uk/ox_scores.php.
362 Method of Administration. The orthopedic hip score questionnaire can be self-administered or 
363 completed over the phone (61,62,76).
364 Scoring. As previously stated, each item (12) contains five possible responses. According to the updated 
365 scoring system, these five responses are scored from 0-4 (worse to best) resulting in a possible overall 
366 score range of 0-48 (most difficulties to least difficulties). The maximum of 2 missing values can be 
367 accepted and replaced by mean values. Overall scores should not be calculated if more than 2 items are 
368 left unanswered. If a patient marks multiple responses for 1 item, the worst response should be used for 
369 calculation of scores (62).
370 Score Interpretation. Categories for the OHS based on data from the Harris Hip Score and translated to 
371 the 0-48 scoring has suggested cut off scores: >41 as excellent, 34-41 as good, 27-33 as fair, and <27 as 
372 poor (77). More recent research has shown that a postoperative OHS of greater than 37.5 is associated 
373 with a successful outcome (78–80). Additionally, clinicians have attempted to use the OHS as a method 
374 of screening out patients who do will not require total hip replacement. Neufeld et al found that an OHS 
375 of 34 or higher was a good predictor of successful nonoperative management of hip arthritis (81). With 
376 use of the classification system described by Kalairajah et al, the OHS at 6 months is a useful predictor of 
377 early revision THA. A poor score was associated with a revision risk of 7.6% compared to a revision risk 
378 of 0.7% in patients with good/excellent scores (67,77). Lastly, normative values were established in 2015 
379 and published by Hamilton et al for patients undergoing THA. They were able to establish normative 
380 values for male and female patients in 4 age categories (<60, 60-70, 70-80, and >80) preoperatively and 
381 12 months after THA (79). 
382 Respondent Burden. The OHS takes between 2-15 minutes to complete. Based on patient interviews, 
383 issues have been raised regarding item clarity and double-barreled questions (82,83). 
384 Administrative Burden. The burden of administering the OHS is minimal. As the OHS is a patient-
385 reported questionnaire, the time to score is short and involves only elementary arithmetic. No specific 
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387 Translations/Adaptations. The OHS has been widely used in many countries. It has been translated and 
388 validated in Japanese, Dutch, German, Turkish, Spanish, Mandarin, Italian, Danish, and with the use of 
389 on-site translator (66,80–89). It has also been translated to French, Iranian, and Korean forms, without 
390 the supporting validation studies (84–86). The Orthopaedic Oxford Scores also include similar 
391 questionnaires for assessing outcome after knee replacement, shoulder replacement, elbow 
392 replacement, ankle replacement, and shoulder instability.
393
394 Pyschometric Information
395 Method of Development. Questions were made based on patient interviews where hip arthritis patients 
396 were asked to report their experiences and frustrations. Patients were involved in content validity of the 
397 questionnaire (61). The OHS underwent item-response theory testing in 2004 by Fitzpartick et al, and 
398 there was an overall good item fit of the data to the Rasch model (87).
399 Acceptability. In a 2000 study, Fitzpatick et al showed that 90% of patients fill out the questionnaire to 
400 completion. In general, older patients and patients with more severe medical problems were less likely 
401 to complete the questionnaire completely compared to younger and healthier patients. In their study, 
402 the most problems referred to the item regarding distance walked before severe pain (88,89). In one 
403 study, up to 10% of English-speaking Americans misinterpreted this item. The authors hypothesize that 
404 the use of “Not at all” as an answer choice implies that the patient never has pain, so this confusion may 
405 lead to an overall underestimation of their hip function. Like other Hip patient reported outcome 
406 measures, the OHS is subject to statistical ceiling effects (approximately 13.5%), however very low levels 
407 of statistical floor effects are observed with the OHS (90,91).
408 Reliability. Several studies have investigated the internal consistency of the OHS preoperatively and 
409 postoperatively. The studies have shown the internal consistency of the OHS to be high (0.84–0.93) 
410 preoperatively and at 3, 6, 12, and 24 months postoperatively (61,92,93). Reproducibility, as measured 
411 by the coefficient of repeatability or inter-class correlations using the Bland and Altman method, has 
412 also been studied extensively and shown to be consistently strong (61,92,94).
413 Validity. During the development of the OHS, patients were asked to comment on and to include hip 
414 related problems not addressed by the draft questionnaire for content validity (61). High correlations 
415 (0.67 – 0.85) have been described when comparing the OHS to other patient reported outcomes of pain 
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417 Ability to Detect Change. The OHS has favorable responsiveness when compared with generic 
418 measures, such as will Short Form 36 and EuroQol 5–domain, and disease-specific measures, including 
419 the Western Ontario, McMaster Universities Osteoarthritis Index, and Arthritis Impact Measurement 
420 Scales. Effect size varied from 2.1-3.1 at 6-24 months after THA and was 1.84 after revision THA 
421 (61,70,90–93,96,97). In 2007, Murray et al estimated the minimal clinically important difference to be 
422 between 3-5 points after joint replacement (62). Further study in 2015 by Beard et al found the minimal 
423 detectable change to be 5 points after THA (80). 
424
425 Critical Appraisal of Overall Value to the Rheumatology Community
426 Strengths. The OHS assess his pain and functional outcomes in patients undergoing total hip 
427 arthroplasty. It has been shown to provide good psychometric properties and has been reported to be a 
428 useful predictor and early revision after total hip arthroplasty.
429 Caveats and Cautions. As previously discussed, the OHS has some questions that may be 
430 misinterpreted, therefore leading to an underestimation of hip pain and function. Additionally, concerns 
431 have been raised regarding the lack of items concerning activities requiring a large angle of hip flexion. 
432 Lastly, it has been shown that 10% patients who was first language is not English may misinterpret one 
433 of items.
434 Clinical Usability. The questionnaire is quick, easy to use, free, and self-administered. Therefore, clinical 
435 usability is high. With that said, a single administration will not provide useful information on individual, 
436 however with repeated administrations useful information can be gleaned.
437 Research Usability. Due to his ease of use and high response rate, the OHS is one of the preferred 
438 patient reported outcome measures for large studies on long-term hip replacement outcomes (65). 
439
440 LEQUESNE INDEX OF SEVERITY FOR OSTEOARTHRITIS OF THE HIP (LISOH)
441 Description
442 Purpose. The LISOH was developed in France in the early 1980’s to evaluate the severity of hip 
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444 osteoarthritis, and as a help in decision making regarding the need for hip replacement (98).  It was 
445 modified in 1997 and became known to some as the Lequesne Algofunctional Index. 
446 Content. The LISOH is an index that covers osteoarthritis-specific symptoms and physical function 
447 disability. It is composite measure of aggregating symptoms and function, which are not graded 
448 separately, where pain is analyzed by 5 items, maximum distance walked by 2 items, and activities of 
449 daily living (ADL) by 4 items (98). This instrument is available in several versions: Interview based, self-
450 administered, and in modified versions due to changed scoring and wording (98–101). 
451 Number of Items. There are 11 items. 
452 Response options/scale. The score ranges from 0 (no pain or disability) to 24 (maximum pain or 
453 disability) and is scored as a sum of all the items (98).
454 Recall period for Items. Not specified. 
455 Examples of Use. The LISOH has been used in both clinical and research settings since its development 
456 in the 1980s. Clinically it has been used to assess the severity of hip osteoarthritis and help with 
457 indications for total hip arthroplasty (101–103). In the research realm, the LISOH has been used to 
458 determine the effectiveness of pharmacologic interventions on hip osteoarthritis and to assess the long-
459 term impact of post-THA rehabilitation (98,104). 
460
461 Practical application
462 How to obtain. The LISOH is free to use and can be accessed at 
463 https://oarsi.org/sites/default/files/docs/2013/lequesne_eng_ndex.pdf.
464 Method of Administration. The LISOH can be self-administered, interviewer-based, or completed by a 
465 clinician during a clinical assessment. 
466 Scoring. The original scoring consists of score ranges from 0-8 for each part of the LISOH questionnaire 
467 (Pain /discomfort, maximum distance walked, and ADL) resulting in a total score range of 0-24. A 
468 modification in 1991 added a question regarding sexual activity to be included when appropriate, 
469 resulting in a total score range of 0-28 (98,99). 
470 Score Interpretation. With the original scoring consisting of a total score range of 0-20 four-point, 0 = no 
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472 handicap, >/= 14 = extremely severe handicap. A score > 11-12 points has been suggested to indicate 
473 need for total hip arthroplasty (103). The questions are suggested to score disabilities connected with a 
474 single hip. There are no indications of how to score in the case of bilateral hip osteoarthritis, which 
475 complicates interpretation of the LISOH in those patients (102).
476 Respondent Burden. The LISOH questionnaire takes less than 5 minutes to complete (102,105,106).
477 Administrative Burden. While scoring of the LISOH questionnaire takes only a few minutes, some 
478 training may be required for use of the questionnaire in an interview based environment to achieve 
479 interobserver reproducibility (98,105).
480 Translations/Adaptations. The LISOH has been translated and validated for hip osteoarthritis in English, 
481 French, German, Turkish, Korean, Spanish, Greek, Persian, and Portuguese (101,102,107–115). 
482
483 Pyschometric Information
484 Method of Development. Developed in France by hip specialists in the early 1980’s through patient 
485 interviews in an adult French population.
486 Acceptability. Several studies have assessed the LISOH questionnaire using Rasch analysis, and 
487 unfavorable results have caused some to question the psychometric properties of the questionnaire. 
488 Furthermore, in direct comparison to the Western Ontario and McMaster Universities Osteoarthritis 
489 Index (WOMAC), the LISOH exhibits worse internal consistency reliability and construct validity in 
490 multiple patient populations (107,110,111,116). Other issues raised regarding the LISOH questionnaire 
491 include the clarity of the items, with one study determining that 2 out of 10 patients in a French 
492 population require additional explanation to the fill out the questionnaire, and poor item response rate, 
493 with one study noting an item response rate of approximately 71% (102,105).
494 Reliability. In general, internal consistency has been found to be satisfactory for the LISOH composite 
495 score (Cronbach’s alpha 0.83-0.84) (101,102,108). With that said, the internal consistency has been 
496 shown to be lower for the pain/discomfort part of the LISOH in comparison to the function part 
497 (Cronbach’s alpha 0.63 vs 0.84, respectively) (101). Satisfactory test–retest reliability has been shown for 
498 the composite score, with interclass correlation coefficient’s ranging from 0.51-0.96 (101,107,111). With 
499 regards to interrater reliability, the interview–based questionnaire had a mean deviation of 0.55 points 
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501 Validity. The construct validity and convergent validity of the LISOH questionnaire have been shown to 
502 be inferior to other patient reported outcome measures (47,101,102,107,111).
503 Ability to Detect Change. The MCID of the LISOH remains to be elucidated. When using the LISOH to 
504 assess the long-term impact of active drug treatment for hip osteoarthritis, an effect size of 1.3-1.8 was 
505 observed (100). 
506
507 Critical Appraisal of Overall Value to the Rheumatology Community
508 Strengths. The LISOH is quick, free, and easy to access. 
509 Caveats and Cautions. Problems have been raised regarding the validity of the LISOH and its utility as a 
510 single measure of outcomes after THA. 
511 Clinical Usability. Given its poor validity and reliability relative to other patient reported outcomes, it is 
512 not recommended to use the LISOH as the sole outcome measure on an individual patient level.
513 Research Usability. Given its ease of use, availability, and relatively high interrater/interobserver 
514 reliability, the LISOH questionnaire may have some utility in the study of THA outcomes in large patient 
515 populations.
516
517 American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire
518 Description
519 Purpose: Throughout the 1990s and early 2000s the AAOS created a series of questionnaires designed 
520 to measure and analyze musculoskeletal outcomes. These assessments covered all body regions in 
521 adults and children.  The hip and knee questionnaire was a specific version of the more general lower 
522 limb questionnaire and was published in 2004. In combination with the SF-36, the AAOS hip and knee 
523 questionnaire was effective at assessing hip and knee conditions and the effects of treatment (117). The 
524 survey was previously available through the AAOS website but has now been replaced by the HOOS and 
525 KOOS surveys. 
526 Content: The questionnaire is identical to the AAOS lower limb questionnaire with the attribution of 
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528 swelling, and function. Specifically, the functional questions assess the respondent’s pain while walking 
529 on flat surfaces, going up or down stairs, and while lying in bed at night. The final two questions assess 
530 the ability to get around and the level of difficulty with taking on and off socks. 
531 Number of Items: 7 items. The worse hip is given preference in the case of bilateral symptoms. 
532 Response Options/Scale: For questions regarding stiffness and swelling, respondents choose from 5 
533 possible options on a Likert scale from “not at all” to “extremely”. For questions regarding pain during 
534 functional activity, there are 7 response options on a Likert scale from “not painful” to “could not do”, as 
535 well as a “could not do for other reasons” option. There are 7 response options for ability to get around 
536 and 6 response options for difficulty with taking on and off socks. 
537 Recall Period for Items: 1 week
538 Cost to use: Free
539 How to obtain: Previously available on aaos.org
540
541 Practical Application 
542 Method of administration: Self-administered questionnaire 
543 Scoring: Standardized and normative scores may be calculated. Unanswered items are not to be 
544 included in calculation of mean scores. In addition, if more than half of the items are missing, a score 
545 cannot be calculated. This includes items marked “could not do for other reasons”, which is considered 
546 equal to a missing response. Instructions on how to calculate standardized and normative scores are 
547 included in a worksheet with the survey. 
548 Score interpretation: Standardized scores are calculated from 0-100, 0 being most disability and 100 
549 being least disability. Normative scores are calculated to a mean population score of 50, with higher 
550 scores indicating higher function (118).  
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552 Administrative burden: The questionnaire can be scored very quickly with a scoring sheet, and within 15 
553 minutes if scored by hand. 
554 Translations/adaptations: The hip and knee questionnaire is an adaptation of the lower limb 
555 questionnaire. There are also sports/knee and foot and ankle adaptations  (117). 
556
557 Psychometric Information:
558 Floor and Ceiling Effects: Not measured (117). 
559 Reliability: The hip and knee questionnaire has a good internal consistency with Cronbach alpha 
560 coefficient of 0.8, calculated from 43 patients with a hip or knee complaint. For test-retest reliability a 
561 Pearson’s correlation coefficient was calculated on 40 patients and found to be 0.91  (117). 
562 Validity: All AAOS instruments were developed by clinicians who continually confirmed the face and 
563 content validity for each questionnaire. Construct validity was obtained by correlating scores from the 
564 hip and knee questionnaire with the AAOS lower limb core scale (r=0.95), the unweighted mean of three 
565 SF-36 physical subscales (r=0.7), and a scale created from a physician assessment of function and pain 
566 (r=0.73 and r=0.69 respectively). In addition, a global score for the WOMAC was calculated and 
567 correlated with the AAOS hip and knee questionnaire (r=0.89) (117). 
568 Responsiveness: There is no direct measure of the hip and knee questionnaire’s responsiveness, but the 
569 lower limb core scale – from which the hip and knee core scale was adapted – has been assessed. An 
570 absolute change score, calculated as the difference between the baseline and follow-up scores, was 
571 found to be moderately correlated with a transition score (r=0.53). This transition score was calculated 
572 from the combined responses of the patient and a physician on their perceptions of improvement over 1 
573 year. Based on the strong correlation of lower limb questionnaire scores to hip and knee questionnaire 
574 scores, it is likely that the hip and knee questionnaire possesses similar ability to detect change. 
575 Minimally important differences: To our knowledge, no MID for the AAOS hip and knee questionnaire 
576 has been calculated. 
577 Generalizability: The AAOS hip and knee questionnaire is applicable to adult populations over age 18 
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579 Use in clinical trials: To our knowledge, the AAOS hip and knee questionnaire has not been used in any 
580 major clinical trials. It has been used to assess outcomes in patients with slipped capital femoral 
581 epiphysis (119), and the AAOS lower limb questionnaire appears in numerous studies covering a broad 
582 range of musculoskeletal topics including outcomes limb lengthening and lower extremity amputation 
583 (120,121). 
584 Critical appraisal of overall value to the rheumatology community
585 Strengths: The AAOS Hip and Knee questionnaire proved to be an effective instrument in assessing hip 
586 and knee conditions and the effect of appropriate treatments. It is a short survey that is easily 
587 administered and scored. A thorough psychometric evaluation was performed in 2004 to demonstrate 
588 its reliability and validity, and in conjunction with the SF-36 it can be an overall effective outcomes 
589 measure. 
590 Caveats and cautions: As patient reported outcomes have become an integral part of the overall effort 
591 to deliver quality care in the United States, other surveys specific to hip and knee outcomes have been 
592 developed and endorsed by the Centers for Medicaid Services (122). The AAOS hip and knee 
593 questionnaire is not included in that group of endorsed outcomes measures. This is likely the reason this 
594 survey is seen less commonly in the literature, and why there have not been any follow-up studies to the 
595 original evaluations of the AAOS questionnaires published in 2004. 
596 Clinical/Research usability: A useful tool given its size and ease of administration, but not practical given 
597 the rising popularity of other surveys as above. 
598
599 Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)
600 Description
601 Purpose: The WOMAC was developed to measure the symptoms and physical disability of patients with 
602 hip or knee arthritis (123). It was created as part of a randomized, controlled trial of two anti-
603 inflammatory medications in the treatment of hip and knee arthritis (124). As such, the WOMAC was 
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605 Content: The survey consists of 3 subscales that evaluate pain during certain positions or movements, 
606 stiffness at different times of day, and difficulty with performing certain activities. 
607 Number of Items: 24 total items. There are 5 items in the pain section, 2 items in the stiffness section, 
608 and 17 items in the functional section.
609 Response Options/Scale: The WOMAC is available in 5-point Likert, 100mm visual analog scale (VAS), 
610 and 11-box numerical rating scales (127). The Likert scale offers five response options ranging from none 
611 to extreme, with corresponding score values from 0-4. The VAS and numerical rating scales offer 
612 responses selected on 100mm or 11-box horizontal scales, ranging from “none” on the left to “extreme” 
613 on the right (128). 
614 Recall Period for Items: 48 hours
615 Cost to use: There is a fee to access the questionnaire and user guide. Fee information is available after 
616 submitting a request to use. 
617 How to obtain: Requests to use the WOMAC for clinical or research purposes must be submitted via the 
618 contact section on the website www.womac.com. 
619 Practical Application 
620 Method of administration: Primarily designed as a self or interview-administered questionnaire. The 
621 WOMAC has been validated for use in person, over the phone, or via computer or mobile phone (129–
622 131). Patients have been shown to respond similarly to paper or online versions (132). 
623 Scoring: For the Likert scale version, the pain, stiffness, and function sections possess potential 
624 summative score totals of 20, 8, and 68 respectively. A global score is calculated by combining the 3 sub-
625 scores (125). For the VAS version, respondents mark a point along the horizontal 100mm line. This is 
626 measured in millimeters and totaled out of 2400 (133). Normative values were published from an 
627 Australian population in 2010 (134). In the case that 2 or more items are missing from the pain subscale, 
628 both items missing from the stiffness subscale, or 4 or more items missing from the functional subscale, 
629 responses are declared invalid and not included for analysis.
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632 Respondent time to complete: 5-10 minutes
633 Administrative burden: Questionnaire responses require approximately 5 minutes to score with 
634 minimal training required. 
635 Translations/adaptations: There have been multiple versions of the WOMAC questionnaire, with the 
636 most recent being version 3.1, updated in 2016. Short-form versions of the WOMAC have been 
637 developed, specific to total hip or total knee replacement, and were found to be equally responsive 
638 compared to the original WOMAC (135). The WOMAC has validated language translations in Arabic, 
639 Chinese, Dutch, Finnish, German, Hebrew, Italian, Japanese, Korean, Moroccan, Singapore, Spanish, 
640 Swedish, Thai, and Turkish (107,108,136–148). 
641 Psychometric Information: 
642 Floor and Ceiling Effects: Floor effects for WOMAC subscales or total scores are generally minimal or 0 
643 (149). However, in one 2005 study, floor effects at 6 months and 2 years following total hip arthroplasty 
644 were significant in the pain (25% and 39%) and stiffness (30% and 46%) subscales (150). In a study of 
645 patients after periacetabular osteotomy, floor effects in the pain and stiffness subscales were <1% and 
646 3% respectively. Floor effects were absent in the function subscale and aggregate score (7). 
647 Ceiling effects are more commonly reported in all WOMAC subscales, particularly in pain and 
648 stiffness (7,95,149). A ceiling effect has been demonstrated in the pain and stiffness subscales when 
649 evaluating patients at 10 weeks and 12 months after hip fracture (149). These effects appear to be 
650 significantly different between young (18%-36%) and old (38%-53%) age groups (149).  In patients after 
651 periacetabular osteotomy, the ceiling effect is more substantial than the floor effect, but still small (4%, 
652 11%, 5%, 2% for pain, stiffness, function, total scores) (7). Findings in the literature are mixed, as one 
653 study demonstrated low ceiling effects of <5% for all WOMAC subscales at 6months and 2 years after 
654 total hip arthroplasty, while another demonstrated significant ceiling effects (14-38%) at 1 year post-
655 operatively (95,150). 
656 Reliability: The WOMAC has demonstrated excellent internal and test-retest reliability. The Cronbach 
657 alpha coefficient for the global score is reported as high as 0.97, with the lowest subscale being the 
658 stiffness subscale (alpha= 0.86) (7,128). Test-retest reliability is equally as strong, with Pearson’s 
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660 WOMAC scores have demonstrated good internal reliability amongst patients after hip fracture, with 
661 Cronbach coefficients ranging from 0.83-0.98 and 0.79-0.97 for young and old age groups respectively 
662 (149). 
663 Validity: Since its creation in the late 1980s, the WOMAC has been extensively validated for patients 
664 with hip and knee arthritis (123). Additional validation has occurred for each of the aforementioned 
665 translations. More recently, the WOMAC has demonstrated good construct validity when compared to 
666 other PROMs. There is strong correlation of total WOMAC and SF-12 scores in patients after hip 
667 fracture, ranging from 0.78-0.84 for young and old age groups respectively (149). Similar results have 
668 been published correlating WOMAC to EQ-5D subscales (149). In patients after periacetabular 
669 osteotomy, Spearman correlation coefficients between WOMAC subscales and the SF-12 physical 
670 subscale are moderate to strong (p>0.5) except for the stiffness subscale (p=0.38) (7).  
671 Responsiveness: For patients with hip osteoarthritis, the standardized response means (SRM) calculated 
672 for the WOMAC are high, exceeding 1.0 (151,152). In 162 patients who underwent total hip arthroplasty 
673 for osteoarthritis there was a mean WOMAC score change of 29, effect size of 1.84, and SRM of 1.6 
674 (153). SRM values at 6 months and 2 years post op have been shown to continue increasing to 1.86 and 
675 1.98 respectively (150). In addition, a statistically significant improvement in scores has been shown up 
676 to 2 years following total hip replacement (150).  In patients who sustain hip fractures, responsiveness is 
677 moderate (SRM=0.66) and small (SRM=0.24) amongst patients less than and greater than 80 years old 
678 respectively (149). These differences are likely due to the fact that WOMAC scores are lowest just before 
679 a hip replacement, and not likely to be obtained prior to a patient sustaining a hip fracture (149). 
680 Minimally important differences: The minimal clinically important difference (MCID) for patients who 
681 underwent total hip arthroplasty for hip arthritis is 10.2 points (153). The MCID for patients who 
682 undergo periacetabular osteotomy for hip pain secondary to hip dysplasia is approximately 11 points for 
683 the total WOMAC score (7). A prospective cohort study of over 1300 patients identified a minimal 
684 clinically important improvement of 7.9 on the WOMAC-function subscale in patients with hip arthritis 
685 who initiated non-operative treatment (154). In addition, mean changes of 9-12mm (100mm normalized 
686 VAS) on WOMAC scales were perceptible by patients with hip and knee osteoarthritis (155). 
687 Generalizability: The WOMAC questionnaire has been applied across wide groups of adult populations. 
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689 validating WOMAC scores in a pediatric population with Perthes disease can be found in the recruitment 
690 phase on clinicaltrials.gov
691 Use in clinical trials: As one of the oldest PROMs validated for assessing the hip, the WOMAC has been 
692 used extensively in studies affecting many types of hip pathology and responses to treatment, including 
693 osteoarthritis, hip dysplasia, and hip trauma. 
694
695 Critical appraisal of overall value to the rheumatology community
696 Strengths: The WOMAC is a historically significant and widely used PROM that is found commonly in the 
697 literature. It has validated short-form versions and has been translated into multiple languages. It also 
698 serves as the foundation for other PROMS like the HOOS. The WOMAC subscales may also be valuable in 
699 stratifying and more thoroughly evaluating data. 
700 Caveats and cautions: The WOMAC is proprietary, and as such, is less accessible and less attractive to 
701 potential clinicians or researchers.  In addition, with 24 items, it is longer than newer, non-proprietary 
702 PROMS like the HOOS-JR. The full WOMAC is also not included in the list of PROMS recognized by the 
703 Centers for Medicaid and Medicare Services. However, the HOOS, a derivative of the WOMAC, is 
704 included on that list. As is common to all functional assessments, some activities included on the 
705 functional subscale may be impossible some patients with severe disease to complete. This may result in 
706 missing data. 
707 Clinical/Research usability: If purchased, the WOMAC is relevant to both clinicians and researchers 
708 alike. It is reliable, valid, and responsive to treatment. It’s ubiquitous presence in hip and knee outcomes 
709 literature makes further use appropriate and guarantees the ability to compare new findings to old data. 
710
711 CONCLUSION
712 We reviewed seven of the most commonly used instruments in assessment of hip outcomes and 
713 function. There has been an extensive body of work in terms of evaluation of psychometric properties 
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715 reference when comparing hip outcome measures and deciding which measures should be used for 
716 research or clinical purposes for researchers and clinicians.
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1156




effects Reliability Validity Responsiveness 
Minimally 
important 
differences Generalizability Used in RCTs








score 0.94. Test-test 
reliability: r=0.93-0.98
Content and construct 
validity correlates with 
similar domains of other 
scores
Responsive to pain, 
function at six-month 
follow-up, weakly 








to adult patients with 















performed by asking 
patients rating item 
importance. Construct 
validity confirmed by 
correlation with other 
scores
Good responsiveness in 
short term and long-
term follow-up up to 2-
years post-operatively




to adult patients with 
hip disabilities or 
undergoing hip 
procedures. HOOS-JR 







Not observed in 
PAO patients. 
Floor effects in 
THA patients 20-
45% in depression 
Internal consistency: 
Cronbach’s alpha 1.00
Not evaluated High responsiveness 
post-operatively in THA 
patients
5 (half of 
normalized SD of 
reported scores)
Generalizable to adult 





frequently used in 
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(PROMIS) domain, 21-26% in 
pain domain. No 
ceiling effects in 
THA patients
PROMIS instruments 
available for pediatric 
patients
Oxford Hip Score 
(OHS)
Ceiling effects 





High correlation with 
content validity when 
compared to other PROMs
High responsiveness 
compared to generic 
measures
Estimated to be 3-5 
points (0-48 point 
scale)
Widely generalizable 
to adult patients with 








Not reported Internal consistency: 
Cronbach’s alpha 0.83-
0.94 for composite 
score, pain/discomfort 
lower at 0.63. Test-
test 0.51-0.96
Construct and convergent 
validity inferior to other 
PROMs
Not reported Unknown Not recommended as 
sole outcome measure 
clinically given poor 
validity and reliability. 
May have some utility 






Hip and Knee 
questionnaire
Not measured Internal consistency: 
Cronbach’s alpha: 0.8. 
Test-test 0.91
Construct validity with 
moderate to high 
correlation to other 
PROMs
Not directly measured Unknown Widely generalizable 
to adult patients with 
hip disabilities or 
undergoing hip 
surgeries









of as minimal, but 
one report of 
significant floor 
effects in pain and 





Good construct validity 
compared to other PROMs
High SRM (>1.0) MCID after THA 
10.2, after PAO 11, 
7.9 in non-op 
management of hip 
OA (Scale  of 0-68)
Widely generalizable 
to adult patients with 
hip disabilities or 
undergoing hip 
surgeries. Currently 
being assessed for 
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effects more 
common up to 
53%
population
1159
A
u
th
o
r 
M
a
n
u
s
c
ri
p
t
